Microsoft, along with the Scripps Translational Science Institute, Navigenics, and Affymetrix will scan up to 10,000 people and provide an analysis of their genetic risk for health conditions that could be changed by lifestyle, including diabetes, obesity, heart attack, and some forms of cancer.